Skip to main content
Erschienen in: Rheumatology International 4/2008

01.02.2008 | Original Article

Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosis

verfasst von: Ozlem Altindag, Ozcan Erel, Neslihan Soran, Hakim Celik, Sahabettin Selek

Erschienen in: Rheumatology International | Ausgabe 4/2008

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to evaluate the total antioxidant status (TAS), total oxidative status (TOS) and oxidative stress index (OSI) in patients with postmenopausal osteoporosis. We also investigate the relation between bone mineral density and oxidative/antioxidative parameters. Thirty-nine patients with osteoporosis and 26 healthy controls were included in the study. Plasma TAS, TOS levels were determined by using a novel automated methods. Plasma TOS and OSI value were significantly higher, and plasma TAS level was lower in patients than in healthy controls (P < 0.001 for all). There was a significant negative correlation between OSI and BMD in lumbar and femoral neck region (r = −0.63, P < 0.001; r = 0.40, P = 0.018). The results of this study indicated that increased osteoclastic activity and decreased osteoblastic activity may be associated with an imbalance between oxidant and antioxidant status in postmenopausal osteoporosis. Therefore, supplementation of antioxidant-enriched diet to the therapy might shed light on the development of novel therapeutic strategies for osteoporosis.
Literatur
1.
Zurück zum Zitat Compston JE, Papapoulos SE, Blanchard F (1998) Report on osteoporosis in the European community: current status and recommendations for the future. Osteoporos Int 8:531–534PubMedCrossRef Compston JE, Papapoulos SE, Blanchard F (1998) Report on osteoporosis in the European community: current status and recommendations for the future. Osteoporos Int 8:531–534PubMedCrossRef
2.
Zurück zum Zitat Gabriel SE, Tosteson AN, Leibson CL, Crowson CS, Pond GR, Hammond CS, Melton LJ (2002) Direct medical costs attributable to osteoporotic fractures. Osteoporos Int 13:323–330PubMedCrossRef Gabriel SE, Tosteson AN, Leibson CL, Crowson CS, Pond GR, Hammond CS, Melton LJ (2002) Direct medical costs attributable to osteoporotic fractures. Osteoporos Int 13:323–330PubMedCrossRef
3.
Zurück zum Zitat The European prospective osteoporosis study (EPOS) group (2002) J Bone Miner Res 17:716–724CrossRef The European prospective osteoporosis study (EPOS) group (2002) J Bone Miner Res 17:716–724CrossRef
4.
Zurück zum Zitat Mueller G, Russell RG (2003) Osteoporosis: pathogenesis and clinical intervention. Biochem Soc Trans 31:462–464PubMedCrossRef Mueller G, Russell RG (2003) Osteoporosis: pathogenesis and clinical intervention. Biochem Soc Trans 31:462–464PubMedCrossRef
5.
Zurück zum Zitat Nathan CF, Tsunawaki S (1986) Secretion of toxic oxygen products by macrophages: regulatory cytokines and their effects on the oxidase. Ciba Found Symp 118:211–230PubMed Nathan CF, Tsunawaki S (1986) Secretion of toxic oxygen products by macrophages: regulatory cytokines and their effects on the oxidase. Ciba Found Symp 118:211–230PubMed
6.
Zurück zum Zitat Brown JP, Josse RG (2002) Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. For the Scientific Advisory Council of the Osteoporosis Society of Canada. CMAJ 167:1–34 Brown JP, Josse RG (2002) Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. For the Scientific Advisory Council of the Osteoporosis Society of Canada. CMAJ 167:1–34
7.
Zurück zum Zitat Gur A, Sarac AJ, Nas K, Cevik R (2004) The relationship between educational level and bone mineral density in postmenopausal women. BMC Fam Pract 5:18PubMedCrossRef Gur A, Sarac AJ, Nas K, Cevik R (2004) The relationship between educational level and bone mineral density in postmenopausal women. BMC Fam Pract 5:18PubMedCrossRef
9.
Zurück zum Zitat Udagawa N, Takahashi N, Akatsu T, Sasaki T, Yamaguchi A, Kodama H, Martin TJ, Suda T (1989) The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology 125:1805–1813PubMedCrossRef Udagawa N, Takahashi N, Akatsu T, Sasaki T, Yamaguchi A, Kodama H, Martin TJ, Suda T (1989) The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology 125:1805–1813PubMedCrossRef
10.
Zurück zum Zitat Salim A, Nacamuli RP, Morgan EF, Giaccia AJ, Longaker MT (2004) Transient changes in oxygen tension inhibit osteogenic differentiation and Runx2 expression in osteoblasts. J Biol Chem 279:40007–40016PubMedCrossRef Salim A, Nacamuli RP, Morgan EF, Giaccia AJ, Longaker MT (2004) Transient changes in oxygen tension inhibit osteogenic differentiation and Runx2 expression in osteoblasts. J Biol Chem 279:40007–40016PubMedCrossRef
11.
Zurück zum Zitat Arnett TR, Gibbons DC, Utting JC, Orriss IR, Hoebertz A, Rosendaal M, Meghji S (2003) Hypoxia is a major stimulator of osteoclast formation and bone resorption. J Cell Physiol 196:2–8PubMedCrossRef Arnett TR, Gibbons DC, Utting JC, Orriss IR, Hoebertz A, Rosendaal M, Meghji S (2003) Hypoxia is a major stimulator of osteoclast formation and bone resorption. J Cell Physiol 196:2–8PubMedCrossRef
12.
Zurück zum Zitat Galli F, Piroddi M, Annetti C, Aisa C, Floridi E, Floridi A (2005) Oxidative stress and reactive oxygen species. Contrib Nephrol 149:240–260PubMedCrossRef Galli F, Piroddi M, Annetti C, Aisa C, Floridi E, Floridi A (2005) Oxidative stress and reactive oxygen species. Contrib Nephrol 149:240–260PubMedCrossRef
13.
Zurück zum Zitat Halliwell B (1994) Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 344:721–724PubMedCrossRef Halliwell B (1994) Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 344:721–724PubMedCrossRef
14.
Zurück zum Zitat Aruoma OI (1996) Characterization of drugs as antioxidant prophylactics. Free Radic Biol Med 20:675–705PubMedCrossRef Aruoma OI (1996) Characterization of drugs as antioxidant prophylactics. Free Radic Biol Med 20:675–705PubMedCrossRef
15.
Zurück zum Zitat Sontakke AN, Tare RS (2002) A duality in the roles of reactive species with respect to bone metabolism. Clin Chim Acta 318:145–148PubMedCrossRef Sontakke AN, Tare RS (2002) A duality in the roles of reactive species with respect to bone metabolism. Clin Chim Acta 318:145–148PubMedCrossRef
16.
Zurück zum Zitat Yang S, Madyastha P, Bingel S, Ries W, Key L (2001) A new superoxide-generating oxidase in murine osteoclasts. J Biol Chem 276:5452–5458PubMedCrossRef Yang S, Madyastha P, Bingel S, Ries W, Key L (2001) A new superoxide-generating oxidase in murine osteoclasts. J Biol Chem 276:5452–5458PubMedCrossRef
17.
Zurück zum Zitat Dreher I, Schuetze N, Baur A, Hesse K, Schneider D, Koehrle J, Jakob F (1998) Selenoproteins are expressed in fetal human osteoblast-like cells. Biochem Biophys Res Commun 245:101–107PubMedCrossRef Dreher I, Schuetze N, Baur A, Hesse K, Schneider D, Koehrle J, Jakob F (1998) Selenoproteins are expressed in fetal human osteoblast-like cells. Biochem Biophys Res Commun 245:101–107PubMedCrossRef
18.
Zurück zum Zitat Fuller K, Lean JM, Bayley KE, Wani MR, Chambers TJ (2000) A role for TGF-β in osteoclast differentiation and survival. J Cell Sci 113:2445–2453PubMed Fuller K, Lean JM, Bayley KE, Wani MR, Chambers TJ (2000) A role for TGF-β in osteoclast differentiation and survival. J Cell Sci 113:2445–2453PubMed
19.
Zurück zum Zitat Varenna M, Binelli L, Zucchi F, Rossi V, Sinigaglia L (2003) Prevalence of osteoporosis and fractures in a migrant population from southern to northern Italy: a cross-sectional, comparative study. Osteoporos Int 14:734–740PubMedCrossRef Varenna M, Binelli L, Zucchi F, Rossi V, Sinigaglia L (2003) Prevalence of osteoporosis and fractures in a migrant population from southern to northern Italy: a cross-sectional, comparative study. Osteoporos Int 14:734–740PubMedCrossRef
20.
Zurück zum Zitat Erel O (2004) A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37:277–285PubMedCrossRef Erel O (2004) A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37:277–285PubMedCrossRef
21.
Zurück zum Zitat Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38:1103–1111PubMedCrossRef Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38:1103–1111PubMedCrossRef
22.
Zurück zum Zitat Lean JM, Davies JT, Fuller K, Jagger CJ, Kirstein B, Partington GA, Urry ZL, Chambers TJ (2003) A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest 112:915–923PubMedCrossRef Lean JM, Davies JT, Fuller K, Jagger CJ, Kirstein B, Partington GA, Urry ZL, Chambers TJ (2003) A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest 112:915–923PubMedCrossRef
23.
Zurück zum Zitat Maggio D, Barabani M, Pierandrei M, Polidori MC, Catani M, Mecocci P, Senin U, Pacifici R, Cherubini A (2003) Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J Clin Endocrinol Metab 88:1523–1527PubMedCrossRef Maggio D, Barabani M, Pierandrei M, Polidori MC, Catani M, Mecocci P, Senin U, Pacifici R, Cherubini A (2003) Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J Clin Endocrinol Metab 88:1523–1527PubMedCrossRef
24.
Zurück zum Zitat Bagis S, Tamer L, Sahin G (2005) Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder? Rheumatol Int 25:188–190PubMedCrossRef Bagis S, Tamer L, Sahin G (2005) Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder? Rheumatol Int 25:188–190PubMedCrossRef
25.
Zurück zum Zitat Yalin S, Bagis S, Polat G, Dogruer N, Cenk Aksit S, Hatungil R, Erdogan C (2005) Is there a role of free oxygen radicals in primary male osteoporosis? Clin Exp Rheumatol 23:689–692PubMed Yalin S, Bagis S, Polat G, Dogruer N, Cenk Aksit S, Hatungil R, Erdogan C (2005) Is there a role of free oxygen radicals in primary male osteoporosis? Clin Exp Rheumatol 23:689–692PubMed
26.
Zurück zum Zitat Wolf RL, Cauley JA, Pettinger M, Jackson R, Lacroix A, Leboff MS (2005) Lack of a relation between vitamin and mineral antioxidants and bone mineral density: results from the Women’s Health Initiative. Am J Clin Nutr 82:581–588PubMed Wolf RL, Cauley JA, Pettinger M, Jackson R, Lacroix A, Leboff MS (2005) Lack of a relation between vitamin and mineral antioxidants and bone mineral density: results from the Women’s Health Initiative. Am J Clin Nutr 82:581–588PubMed
27.
Zurück zum Zitat Garrett IR, Boyce BF, Oreffo RO, Bonewald L, Poser J, Mundy GR (1990) Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest 85:632–639PubMed Garrett IR, Boyce BF, Oreffo RO, Bonewald L, Poser J, Mundy GR (1990) Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest 85:632–639PubMed
28.
Zurück zum Zitat Eghbali-Fatourechi G, Khosla S, Sanal A, Boyle WC, Lacey DL, Riggs BL (2003) Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 111:121–130CrossRef Eghbali-Fatourechi G, Khosla S, Sanal A, Boyle WC, Lacey DL, Riggs BL (2003) Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 111:121–130CrossRef
29.
Zurück zum Zitat Pacifici R (1996) Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11:1043–1051PubMedCrossRef Pacifici R (1996) Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11:1043–1051PubMedCrossRef
30.
Zurück zum Zitat Vural P, Akgul C, Canbaz M (2005) Effects of menopause and tibolone on antioxidants in postmenopausal women. Ann Clin Biochem 42:220–223PubMedCrossRef Vural P, Akgul C, Canbaz M (2005) Effects of menopause and tibolone on antioxidants in postmenopausal women. Ann Clin Biochem 42:220–223PubMedCrossRef
31.
Zurück zum Zitat Isomura H, Fujie K, Shibata K, Inoue N, Iizuka T, Takebe G, Takahashi K, Nishihira J, Izumi H, Sakamoto W (2004) Bone metabolism and oxidative stress in postmenopausal rats with iron overload. Toxicology 197:93–100PubMedCrossRef Isomura H, Fujie K, Shibata K, Inoue N, Iizuka T, Takebe G, Takahashi K, Nishihira J, Izumi H, Sakamoto W (2004) Bone metabolism and oxidative stress in postmenopausal rats with iron overload. Toxicology 197:93–100PubMedCrossRef
32.
Zurück zum Zitat Melhus H, Michaelsson K, Holmberg L, Wolk A, Ljunghall S (1999) Smoking, antioxidant vitamins, and the risk of hip fracture. J Bone Miner Res 14:129–135PubMedCrossRef Melhus H, Michaelsson K, Holmberg L, Wolk A, Ljunghall S (1999) Smoking, antioxidant vitamins, and the risk of hip fracture. J Bone Miner Res 14:129–135PubMedCrossRef
33.
Zurück zum Zitat Lee NK, Choi YG, Baik JY, Han SY, Jeong DW, Bae YS, Kim N, Lee SY (2005) A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 106:852–859PubMedCrossRef Lee NK, Choi YG, Baik JY, Han SY, Jeong DW, Bae YS, Kim N, Lee SY (2005) A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 106:852–859PubMedCrossRef
34.
Zurück zum Zitat Kim HJ, Chang EJ, Kim HM, Lee SB, Kim HD, Su Kim G, Kim HH (2006) Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha. Free Radic Biol Med 40:1483–1493PubMedCrossRef Kim HJ, Chang EJ, Kim HM, Lee SB, Kim HD, Su Kim G, Kim HH (2006) Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha. Free Radic Biol Med 40:1483–1493PubMedCrossRef
35.
Zurück zum Zitat Varanasi SS, Francis RM, Berger CE, Papiha SS, Datta HK (1999) Mitochondrial DNA deletion associated oxidative stress and severe male osteoporosis. Osteoporos Int 10:143–149PubMedCrossRef Varanasi SS, Francis RM, Berger CE, Papiha SS, Datta HK (1999) Mitochondrial DNA deletion associated oxidative stress and severe male osteoporosis. Osteoporos Int 10:143–149PubMedCrossRef
Metadaten
Titel
Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosis
verfasst von
Ozlem Altindag
Ozcan Erel
Neslihan Soran
Hakim Celik
Sahabettin Selek
Publikationsdatum
01.02.2008
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 4/2008
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-007-0452-0

Weitere Artikel der Ausgabe 4/2008

Rheumatology International 4/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.